Alprolix 1000 Unit (Recombinant Human Coagulation Factor Ix, Fc Fusion Protein KIT) 1000 UNIT

Alprolix 1000 Unit is a recombinant human coagulation factor IX, FC fusion protein used for managing bleeding episodes in hemophilia B. This intravenous kit provides targeted support for blood clotting.

Strength

1000 UNIT

Manufacturer / TM Owner

SANOFI-AVENTIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Alprolix 1000 Unit is primarily used for the control and prevention of bleeding episodes in individuals with hemophilia B. It works by replacing the missing clotting factor IX, which is essential for normal blood coagulation. This medication is often used in both routine prophylaxis and on-demand treatment scenarios to manage bleeding risks effectively.

Side Effects

Common effects of Alprolix 1000 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild to moderate headaches or joint pain. These effects are generally temporary and subside as the body adjusts to the medication.

Precautions & Warnings

Alprolix 1000 Unit should be handled with care, ensuring proper storage and administration as directed. Users should be aware of potential allergic reactions and seek medical attention if severe symptoms occur. It is important to follow healthcare provider guidelines for safe and effective use.

Avoid Interactions

Alprolix 1000 Unit may interact with certain medications that affect blood clotting, such as anticoagulants. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol consumption should also be moderated, as it may influence the effectiveness of the treatment.

Frequently Asked Questions

Alprolix 1000 Unit is used to manage and prevent bleeding episodes in individuals with hemophilia B by replacing the missing clotting factor IX.

Alprolix 1000 Unit is administered intravenously, typically by a healthcare professional or trained individual.

Common side effects may include localized reactions at the injection site, headaches, and joint pain.

Yes, Alprolix 1000 Unit can be used for routine prophylaxis to prevent bleeding episodes in individuals with hemophilia B.

Alprolix 1000 Unit should be used under the guidance of a healthcare provider, who can assess individual health conditions and potential risks.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.